BE Therapeutics
Biotechnology Research
New York, United States
6 employees
- Employees
- 6
- Contacts
- 1
- Emails
- 1
BE Therapeutics Overview
- Headquarters
- New York, United States
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About BE Therapeutics
What if we could restore brain function for the tens of millions of individuals who suffer from permanent brain damage? Strokes, traumas, neurodegeneration, and tumors can all cause permanent brain damage, but as of now there are no treatments that enable affected individuals to regain lost abilities. Consequently, they remain dependent on costly care for the rest of their lives. The aim of the Brain Repair program is to develop methods for replacing damaged brain tissue, enabling patients to regain lost function. The success of BE Therapeutics will bring relief to the millions of people world-wide suffering from permanent brain damage.
BE Therapeutics Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
BE Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Monika Hospodiuk Karwowski, Ph.d. | Vascularization - Soft Tissue | Brooklyn, New York, United States |
View
|
| Pascale Eede, Phd | Life Science Vc - Associate |
View
|
|
| Wyndham Batchelor | Senior Tissue Engineer (Senior | New York, United States |
Email
|
Employees by Management Level
Senior / Lead
1 profile
Individual contributor
1 profile
Associate / junior
1 profile
Compare Similar Companies to BE Therapeutics
Chan Zuckerberg Initiative
Non-Profit Organizations
Be Biopharma
Biotechnology
Apollo Health Ventures
Venture Capital And Private Equity Principals
Sapience Therapeutics, Inc.
Biotechnology Research
NovaBioAssays
Biotechnology Research
Phenocell (Axol Bioscience Ltd.)
Biotechnology Research
Alkyon Therapeutics
Biotechnology Research
HydraDAO
Biotechnology Research
Apollo Ventures
Venture Capital And Private Equity Principals
Bioharmony Therapeutics
Biotechnology